Picture of Shenzhen Hepalink Pharmaceutical Co logo

9989 Shenzhen Hepalink Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Shenzhen Hepalink Pharmaceutical Posts Qtrly Net Profit Attributable RMB155.0 Mln

April 29 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd  002399.SZ :
    * QTRLY NET PROFIT ATTRIBUTABLE RMB155.0 MILLION VERSUS
RMB66.5
MILLION
    * QTRLY OPERATING REVENUE RMB1.37 BILLION VERSUS RMB1.30
BILLION


Further company coverage:  002399.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shenzhen Hepalink Pharmaceutical Co

See all news